The Ethics of Thrombolytic Trials Beyond 3 (or 4.5) Hours: Randomized Controlled Trials Are Required to Change Clinical Practice
Stroke 40:1545, Donnan,G.A. &Davis,S.M., 2009
Chronic Disorders of Consciousness
Lancet 367:1181-1192, Bernat,J.L., 2006
In Utero Magnetic Resonance Imaging for Brain and Spinal Abnormalities in Fetuses
BMJ 331:562-565, Griffiths,P.D.,et al, 2005
Ethical Considerations in Surgical Decompression for Stroke
Stroke 53:2676-2682, Shlobin, N.A.,et al, 2022
End of Life
Neurol 93:729-734, Masdeu, J.C.,et al, 2019
Ethical, Palliative, and Policy Considerations in Disorders of Consciousness
Neurol 91:471-475, Fins, J.J. & Bernat, J.L., 2018
Outcome Following Decompressive Hemicraniectomy for Malignant Cerebral Infarction
Stroke 46:2695-26598, Honeybul, S.,et al, 2015
Legal and Ethical Implications in the Evaluation and Management of Sports-Related Concussion
Neurol 83:352-359, Kirschen, M.P.,et al, 2014
"Undiagnosing" Multiple Sclerosis
Neurol 78:1986-1991,1904, Solomon, A.J.,et al, 2012
An Update on Brain Death Criteria A Simple Algorithm with Complex Questions
The Neurologist 17-237-240, Scripko, P.D.,et al, 2011
Sedation for the Imminently Dying: Survey Results from the AAN Ethics Section
Neurol 74:1303-1309, Russell,J., et al, 2010
Clinicopath Conf, Oocyte Retrieval After Anoxic Brain Injury
NEJM: 363:276-283, Case 24-2010, 2010
Huntingtons Disease
BMJ 341:34-40, Novak,M.J. &Tabrizi,S.J., 2010
Neurologic Prognosis After Cardiac Arrest
NEJM 361:605-611, Young,G.B., 2009
Should Asymptomatic Patients with Hereditary Haemorrhagic Telangiectasia (HHT) be Screened for Cerebral Vascular Malformations? Data from 22 061 years of HHT Patient Life
JNNP 74:743-748, Easey,A.J.,et al, 2003
Current Concepts in Mild Cognitive Impairment
Arch Neurol 58:1985-1992, Petersen,R.C.,et al, 2001
Rethinking the Role of Tube Feeding in Patients with Advanced Dementia
NEJM 342:206-210, Gillick,M.R., 2000
End-of-Life Care,A Survey of US Neurologists' Attitudes, Behavior, and Knowledge
Neurol 53:284-293, Carver,A.C.,et al, 1999
Consent Issues in the Management of Cerebrovascular Diseases, A Position Paper of the American Academy of Neurology Ethics and Humanities Subcommittee
Neurol 53:9-11, , 1999
Use of Placebo Surgery in Controlled Trials of a Cellular-Based Therapy for Parkinson's Disease
NEJM 341:988-992, Freeman,T.B.,et al, 1999
Tube Feeding in Patients with Advanced Dementia,A Review of the Evidence
JAMA 282:1365-1370, Finucane,T.E.,et al, 1999
Assisted Suicide
Euthanasia, and the Neurologist, The Ethics and Humanities Subcom of AAN, Neurol 50:596-59898., , 1998
When is Thrombolysis Justified in Patients with Acute Stroke? A Bioethical Perspective
Stroke 28:214-218, Furlan,A.J.&Kanoti,G., 1997
The Clinical Introduction of Genetic Testing for Alzheimer Disease, An Ethical Perspective
JAMA 277:832-836, Post,S.G.,et al, 1997
Withdrawing Intensive Life-Sustaining Treatment-Recommendations for Compassionate Clin Mgmt
NEJM 336:652-657, Brody,H.,et al, 1997
Variation in the Use of Do-Not-Resuscitate Orders in Patients with Stroke
Arch Int Med 157:1841-1847, Shepardson,L.B.,et al, 1997
Outcomes of Stroke Patients in Medicare Fee for Service and Managed Care
JAMA 278:119-124, 1611997., Retchin,S.M.,et al, 1997
Genetic Testing for Alzheimer Disease, Practical and Ethical Issues
Arch Neurol 54:1226-1229, Roses,A.D., 1997
Agreement on Disease-Specific Criteria for Do-Not-Resuscitate Orders in Acute Stroke
Stroke 27:232-237, Alexandrov,A.V.,et al, 1996
No to DNR Orders in Acute Stroke
Lancet 347:848, Landi,G., 1996
Apolipoprotein E Genotyping in Alzheimer's Disease
Lancet 347:1091-1095, Tanzi,R.,et al, 1996
Physicians'Attitudes about the Care of Patients in the Persistent Vegetative State:A National Survey
Ann Int Med 125:104-147, Payne,K.,et al, 1996
Palliative Care in Neurology
Neurol 46:870-872, 5981996., Bernat,J.L.,et al, 1996
Ethical Issues in the Management of the Demented Patient
Neurol 46:1180-1183, 5981996., Bernat,J.L.,et al, 1996
Do-Not-Resuscitate Orders in Acute Stroke
Neurol 45:634-640, 6151995., Alexandrov,A.V.,et al, 1995
Statement of Use of Apolipoprotein E Testing for Alzheimer Disease
JAMA 274:1627-1629, Farrer,L.A.,et al, 1995
Apoliprprotein E E4 Allele & the Lifetime Risk of Alzheimer's Disease:What Physicians Know, & What They Should Know
Arch Neurol 52:1074-1079, Seshadri,S.,et al, 1995
Clinical Consequences of Isolating the Gene for Huntington's Disease
BMJ 307:397-398, Harper,P.S., 1993
Persistent Vegetative State
ANA Comm on Ethical Affairs, Ann Neurol 33:386-390, 391993., , 1993
Withdrawing Life-Sustaining Treatment, lessons from Nancy Cruzan
Arch Int Med 152:25-27, Fairman,R.P., 1992
Murder, Insanity, and Medical Expert Witnesses
ARch Neurol 49:608-611, Ciccone,J.R., 1992
Outlook for the Child with a Cephalocele
Pediatrics 90:914-919, Brown,M.S.,et al, 1992
What Does Cruzan Mean to the Practicing Physician?
Arch Int Med 151:925-928, 853-8541991., White,B.D.,et al, 1991
Withholding and Withdrawal of Life Support from the Critically Ill
NEJM 322:309-315, Smedira,N.G.,et al, 1990
Persistent Vegetative State and the Decision to Withdraw or Withhold Life Support
Council Report, JAMA 263:426-4301990., , 1990
Persistent Vegetative State
Correspondence, Neurol 40:384-3861990., , 1990
The Infant with Anencephaly
Med Task Force on Anencephaly, NEJM 322:669-6741990., , 1990
Changing Attitudes and Practices in Forgoing Life-Sustaining Treatments
JAMA 263:2211-2215, 22211990., Sprung,C.L., 1990
Ethics of Life Support in Patients with Severe Stroke
Stroke 20:1107-1112, Asplund,K.&Britton,M., 1989